{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:10:40Z","timestamp":1793643040390,"version":"4.5.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32#CA078586"],"award-info":[{"award-number":["T32#CA078586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1245\/s10434-020-08733-x","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T15:03:33Z","timestamp":1593011013000},"page":"5074-5083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Metastatic Colorectal Cancers with Mismatch Repair Deficiency Result in Worse Survival Regardless of Peritoneal Metastases"],"prefix":"10.1245","volume":"27","author":[{"given":"Scott K.","family":"Sherman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Schuitevoerder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos H. F.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran K.","family":"Turaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"8733_CR1","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1158\/1078-0432.CCR-14-0332","volume":"20","author":"S Venderbosch","year":"2014","unstructured":"Venderbosch S, Nagtegaal ID, Maughan TS, et al. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies. Clin Cancer Res. 2014;20:5322\u201330.","journal-title":"Clin Cancer Res"},{"key":"8733_CR2","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1200\/JCO.2012.45.1674","volume":"31","author":"B Heald","year":"2013","unstructured":"Heald B, Plesec T, Liu X, et al. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center. J Clin Oncol. 2013;31:1336\u201340.","journal-title":"J Clin Oncol"},{"key":"8733_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357:409\u201313.","journal-title":"Science"},{"key":"8733_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cgh.2018.06.038","volume":"17","author":"FA Sinicrope","year":"2019","unstructured":"Sinicrope FA. Evaluating the combination of microsatellite instability and mutation in BRAF as prognostic factors for patients with colorectal cancer. Clin Gastroenterol Hepatol. 2019;17:391\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8733_CR5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.5858\/2010-0613-RAIR.1","volume":"135","author":"A Bedeir","year":"2011","unstructured":"Bedeir A, Krasinskas AM. Molecular diagnostics of colorectal cancer. Arch Pathol Lab Med. 2011;135:578\u201387.","journal-title":"Arch Pathol Lab Med"},{"key":"8733_CR6","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1002\/cncr.26086","volume":"117","author":"B Tran","year":"2011","unstructured":"Tran B, Kopetz S, Tie J, et al. Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer. Cancer. 2011;117:4623\u201332.","journal-title":"Cancer"},{"key":"8733_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1200\/JCO.2005.01.086","volume":"23","author":"S Popat","year":"2005","unstructured":"Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23:609\u201318.","journal-title":"J Clin Oncol"},{"key":"8733_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.prp.2012.07.003","volume":"208","author":"F Benedix","year":"2012","unstructured":"Benedix F, Meyer F, Kube R, et al. Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma. Pathol Res Pract. 2012;208:592\u20137.","journal-title":"Pathol Res Pract"},{"key":"8733_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.6004\/jnccn.2018.0021","volume":"16","author":"AB Benson","year":"2018","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al. NCCN guidelines insights: colon cancer, version 2.2018. J Natl Compr Cancer Netw.\u00a02018;16:359\u201369.","journal-title":"J Natl Compr Cancer Netw."},{"key":"8733_CR10","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1245\/s10434-020-08315-x","volume":"27","author":"Chicago Consensus Working Group","year":"2020","unstructured":"Chicago Consensus Working Group. The Chicago consensus on peritoneal surface malignancies: management of colorectal metastases. Ann Surg Oncol. 2020;27:1761\u20137.","journal-title":"Ann Surg Oncol."},{"key":"8733_CR11","doi-asserted-by":"publisher","first-page":"djw272","DOI":"10.1093\/jnci\/djw272","volume":"109","author":"J Taieb","year":"2017","unstructured":"Taieb J, Le Malicot K, Shi Q, et al. Prognostic value of BRAF and KRAS mutations in MSI and MSS stage III colon cancer. J Natl Cancer Inst. 2017;109:djw272.","journal-title":"J Natl Cancer Inst."},{"key":"8733_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman MJ, Lonardi S, Wong KYM, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol. 2018;36:773\u20139.","journal-title":"J Clin Oncol"},{"key":"8733_CR13","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, Uram JN, Wang H, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372:2509\u201320.","journal-title":"N Engl J Med"},{"key":"8733_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40425-018-0342-x","volume":"6","author":"MM Boyiadzis","year":"2018","unstructured":"Boyiadzis MM, Kirkwood JM, Marshall JL, Pritchard CC, Azad NS, Gulley JL. Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease. J Immunother Cancer. 2018;6:35.","journal-title":"J Immunother Cancer"},{"key":"8733_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/jso.21601","volume":"102","author":"J Esquivel","year":"2010","unstructured":"Esquivel J, Chua TC, Stojadinovic A, et al. Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol. 2010;102:565\u201370.","journal-title":"J Surg Oncol"},{"key":"8733_CR16","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1245\/s10434-012-2236-3","volume":"19","author":"RN Low","year":"2012","unstructured":"Low RN, Barone RM. Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol. 2012;19:1394\u2013401.","journal-title":"Ann Surg Oncol"},{"key":"8733_CR17","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1245\/s10434-018-6490-x","volume":"25","author":"R Jacobson","year":"2018","unstructured":"Jacobson R, Sherman SK, Dahdaleh F, Turaga KK. Peritoneal metastases in colorectal cancer. Ann Surg Oncol. 2018;25:2145\u201351.","journal-title":"Ann Surg Oncol"},{"key":"8733_CR18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s11605-019-04441-4","volume":"24","author":"L Xue","year":"2019","unstructured":"Xue L, Hyman NH, Turaga KK, Eng OS. Peritoneal metastases in colorectal cancer: biology and barriers. J Gastrointest Surg. 2019;24:720\u20137.","journal-title":"J Gastrointest Surg."},{"key":"8733_CR19","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1245\/s10434-020-08316-w","volume":"27","author":"Chicago Consensus Working Group","year":"2020","unstructured":"Chicago Consensus Working Group. The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms. Ann Surg Oncol. 2020;27:1753\u201360.","journal-title":"Ann Surg Oncol."},{"key":"8733_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S1470-2045(17)30336-4","volume":"18","author":"J Tseng","year":"2017","unstructured":"Tseng J, Bryan DS, Poli E, Sharma M, Polite BN, Turaga KK. Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer. Lancet Oncol. 2017;18:711\u20132.","journal-title":"Lancet Oncol"},{"key":"8733_CR21","unstructured":"Surgeons ACo. NCDB participant user file: citing data from the NCDB. 2020. Retrieved 19 Feb 2020 at http:\/\/ncdbpuf.facs.org\/node\/412."},{"key":"8733_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","volume":"17","author":"M Schemper","year":"1996","unstructured":"Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17:343\u201346.","journal-title":"Control Clin Trials"},{"key":"8733_CR23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"8733_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/DCR.0b013e3181c703a4","volume":"53","author":"F Benedix","year":"2010","unstructured":"Benedix F, Kube R, Meyer F, et al. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum. 2010;53:57\u201364.","journal-title":"Dis Colon Rectum"},{"key":"8733_CR25","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s11605-015-3026-6","volume":"20","author":"M Yahagi","year":"2016","unstructured":"Yahagi M, Okabayashi K, Hasegawa H, Tsuruta M, Kitagawa Y. The worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and meta-analysis. J Gastrointest Surg. 2016;20:648\u201355.","journal-title":"J Gastrointest Surg"},{"key":"8733_CR26","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17:1709\u201319.","journal-title":"Lancet Oncol"},{"key":"8733_CR27","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.6004\/jnccn.2017.7011","volume":"15","author":"ME Charlton","year":"2017","unstructured":"Charlton ME, Kahl AR, Greenbaum AA, et al. KRAS testing, tumor location, and survival in patients with stage IV colorectal cancer: SEER 2010\u20132013. J Natl Compr Cancer Netw. 2017;15:1484\u201393.","journal-title":"J Natl Compr Cancer Netw"},{"key":"8733_CR28","doi-asserted-by":"publisher","first-page":"e173580","DOI":"10.1001\/jamaoncol.2017.3580","volume":"4","author":"T Shaikh","year":"2018","unstructured":"Shaikh T, Handorf EA, Meyer JE, Hall MJ, Esnaola NF. Mismatch repair deficiency testing in patients with colorectal cancer and nonadherence to testing guidelines in young adults. JAMA Oncol. 2018;4:e173580.","journal-title":"JAMA Oncol"},{"key":"8733_CR29","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1245\/s10434-013-3169-1","volume":"20","author":"SH Kim","year":"2013","unstructured":"Kim SH, Shin SJ, Lee KY, et al. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study. Ann Surg Oncol. 2013;20:3407\u201313.","journal-title":"Ann Surg Oncol"},{"key":"8733_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1245\/s10434-019-07879-7","volume":"27","author":"A Stein","year":"2020","unstructured":"Stein A, Strong E, Clark Gamblin T, et al. Molecular and genetic markers in appendiceal mucinous tumors: a systematic review. Ann Surg Oncol. 2020;27:85\u201397.","journal-title":"Ann Surg Oncol"},{"key":"8733_CR31","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1200\/JCO.18.02258","volume":"37","author":"HJ Lenz","year":"2019","unstructured":"Lenz HJ, Ou FS, Venook AP, et al. Impact of consensus molecular subtype on survival in patients with metastatic colorectal cancer: results from CALGB\/SWOG 80405 (Alliance). J Clin Oncol. 2019;37:1876\u201385.","journal-title":"J Clin Oncol"},{"key":"8733_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/sj.bjc.6604867","volume":"100","author":"M Koopman","year":"2009","unstructured":"Koopman M, Kortman GA, Mekenkamp L, et al. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br J Cancer. 2009;100:266\u201373.","journal-title":"Br J Cancer"},{"key":"8733_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.cgh.2018.04.015","volume":"17","author":"H Blaker","year":"2019","unstructured":"Blaker H, Alwers E, Arnold A, et al. The association between mutations in BRAF and colorectal cancer-specific survival depends on microsatellite status and tumor stage. Clin Gastroenterol Hepatol. 2019;17:455\u201362.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8733_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11523-019-00690-0","volume":"15","author":"R Cohen","year":"2020","unstructured":"Cohen R, Rousseau B, Vidal J, Colle R, Diaz LA Jr, Andre T. Immune checkpoint inhibition in colorectal cancer: microsatellite instability and beyond. Target Oncol. 2020;15:11\u201324.","journal-title":"Target Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08733-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08733-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08733-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T09:41:44Z","timestamp":1723110104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08733-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":34,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["8733"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08733-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]},"assertion":[{"value":"26 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}